Why the study?
Modifiable lifestyle and risk factor management for AF prevention and treatment remains underrecognized, underused, and understudied despite the rising prevalence of reversible AF risk factors.
Does lifestyle and risk factor modification prevent or reduce the burden of atrial fibrillation?
Does lifestyle and risk factor modification prevent or reduce the burden of atrial fibrillation?
This AHA scientific statement emphasizes that integrating lifestyle and risk factor modification into routine care is essential for the primary and secondary prevention of atrial fibrillation.
Supports risk factor modification in AF prevention; extends observational data while leaving RCT confirmation open.
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is associated with substantial morbidity, mortality, and healthcare use. Great strides have been made in stroke prevention and rhythm control strategies, yet reducing the incidence of AF has been slowed by the increasing incidence and prevalence of AF risk factors, including obesity, physical inactivity, sleep apnea, diabetes mellitus, hypertension, and other modifiable lifestyle-related factors. Fortunately, many of these AF drivers are potentially reversible, and emerging evidence supports that addressing these modifiable risks may be effective for primary and secondary AF prevention. A structured, protocol-driven multidisciplinary approach to integrate lifestyle and risk factor management as an integral part of AF management may help in the prevention and treatment of AF. However, this aspect of AF management is currently underrecognized, underused, and understudied. The purpose of this American Heart Association scientific statement is to review the association of modifiable risk factors with AF and the effects of risk factor intervention. Implementation strategies, care pathways, and educational links for achieving impactful weight reduction, increased physical activity, and risk factor modification are included. Implications for clinical practice, gaps in knowledge, and future directions for the research community are highlighted.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: